Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.
about
Alternative approaches to antifungal therapiesInvolvement of β-defensin 130 (DEFB130) in the macrophage microbicidal mechanisms for killing Plasmodium falciparumPerspectives for clinical use of engineered human host defense antimicrobial peptidesAntibacterial and antiviral roles of a fish β-defensin expressed both in pituitary and testis.Immunostimulation in the era of the metagenome.Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity.Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis.Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3.Effect of selectively introducing arginine and D-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins.Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?In vivo expression of antimicrobial peptides in atopic dermatitis.Antifungal effects of synthetic human β-defensin 3-C15 peptide.Tissue-specific human beta-defensins (HBD)-1, HBD-2 and HBD-3 secretion profile from human amniochorionic membranes stimulated with Candida albicans in a two-compartment tissue culture systemThe emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.Role of host-defence peptides in eye diseasesAntimicrobial peptide elicitors: new hope for the post-antibiotic era.Defensins: antifungal lessons from eukaryotesInterplay between Candida albicans and the antimicrobial peptide armory.Antimicrobial peptides from fish.Vitamin D inhibits the growth of and virulence factor gene expression by Porphyromonas gingivalis and blocks activation of the nuclear factor kappa B transcription factor in monocytes.Green tea extract and its major constituent, epigallocatechin-3-gallate, induce epithelial beta-defensin secretion and prevent beta-defensin degradation by Porphyromonas gingivalis.Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines.Synthetic Nucleic Acid Analogues in Gene Therapy: An Update for Peptide-Oligonucleotide Conjugates.Exploring the mechanisms of action of human secretory RNase 3 and RNase 7 against Candida albicansCentral Role for Dermal Fibroblasts in Skin Model Protection against Candida albicans.An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule.β-Defensin 1 plays a role in acute mucosal defense against Candida albicans.A hybrid cationic peptide composed of human β-defensin-1 and humanized θ-defensin sequences exhibits salt-resistant antimicrobial activity.Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens.Probing Oligomerized Conformations of Defensin in the Membrane.
P2860
Q26999896-BC1D76C2-F2DC-486A-9741-8C11281E2F0EQ30179429-09BC4878-02A0-4C36-924A-E934717388F4Q33700825-924CE498-513D-4CCA-B563-FEEC588B3BA0Q33781218-A97F50AA-A599-43BB-9516-46DE1B359B03Q33827416-1F159E13-F347-44E5-8F13-581F94F14E21Q33876601-8DA164F8-0633-475C-BA62-BBCBEB960694Q34663197-FDF7ED33-F25F-4242-9F24-E0A3EE0E41E6Q34739171-4A1EACCA-608A-4D03-9BA8-8D9C37401259Q35006475-4CCA0597-1A9C-410E-9F7C-21AF7F66488FQ35173769-FBAE54B6-8C5A-4808-BED5-3B79E930B955Q35744702-B2C339A5-1BD7-4453-B90A-23396F64EE16Q36023412-B3A305E1-0475-4155-8234-0D536FE5101CQ36390494-A36D2EEC-19B9-4EF2-A0B3-927A3777DDBDQ36587156-4AB29B92-9DDC-453D-836A-1DCE7B4460C8Q36799596-F360CC4D-D48B-49CC-99AF-F5498981B250Q38060524-4D4A81E6-EC4F-4C4F-BC68-2A8D5213F604Q38201011-02B129C6-C5B6-479B-9F2C-9E334318F35BQ38222087-EA162D1F-AE62-4350-99E5-A0F3C9305953Q38644688-DDC0482C-9019-4BEA-BE44-80E8B1CF1F09Q38841858-52A6677D-0E28-49EE-A633-2ACFAF05D934Q39065647-AFD6FF51-EDED-411F-A4BE-4CA9C1A0922BQ39203205-28362015-75B7-4127-9366-D7FB6A811597Q39373677-DBC46468-2923-44D5-AFD3-40E3DD23B342Q39699474-2A84A843-CCFE-4B2A-BCD9-7A3531498826Q40268085-542E4297-60F5-4D04-B85B-721215C933E6Q41033958-46A95E0A-57E0-4E5B-A421-F696C724D41BQ41539981-A94F2FE1-6BD2-4E04-8A02-BEB9B13B726CQ41687406-E48A3A73-9CE7-411B-8715-DC0C916C4E1BQ45800178-61020EA2-90BE-41D6-8248-5BBB0E93887AQ46643064-C7D2D679-F8FF-404C-9C9E-4198A531D9E9
P2860
Antifungal activities of human beta-defensins HBD-1 to HBD-3 and their C-terminal analogs Phd1 to Phd3.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@ast
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@en
type
label
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@ast
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@en
prefLabel
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@ast
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@en
P2093
P2860
P356
P1476
Antifungal activities of human ...... terminal analogs Phd1 to Phd3.
@en
P2093
Nandini Rangaraj
Ramakrishnan Nagaraj
Viswanatha Krishnakumari
P2860
P304
P356
10.1128/AAC.00470-08
P407
P577
2008-09-22T00:00:00Z